FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

32701411000001103: Tagrisso 80mg tablets (AstraZeneca UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99837801000001116 Tagrisso 80mg tablets (AstraZeneca UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99837901000001110 Tagrisso 80mg tablets (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Is a Osimertinib 80mg tablets true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has active ingredient Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Is a Tagrisso true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has specific active ingredient Osimertinib mesylate false Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Osimertinib false Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Osimertinib true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has basis of strength substance Osimertinib true Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has specific active ingredient Osimertinib mesilate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tagrisso 80mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has AMP True Tagrisso 80mg tablets (AstraZeneca UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start